YIDU TECH INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.15 HKD | +7.79% |
|
+22.49% | -18.18% |
| Sales 2024 * | 814M 112M 880M | Sales 2025 * | 1.02B 141M 1.1B | Capitalization | 3.78B 522M 4.08B |
|---|---|---|---|---|---|
| Net income 2024 * | -211M -29.12M -228M | Net income 2025 * | -84M -11.59M -90.77M | EV / Sales 2024 * | 0.26 x |
| Net cash position 2024 * | 3.57B 492M 3.85B | Net cash position 2025 * | 3.59B 495M 3.88B | EV / Sales 2025 * | 0.19 x |
| P/E ratio 2024 * |
-17.4
x | P/E ratio 2025 * |
-43.5
x | Employees | 944 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.77% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +7.53% | ||
| 1 week | +22.49% | ||
| Current month | +3.24% | ||
| 1 month | +2.99% | ||
| 3 months | +8.38% | ||
| 6 months | +6.43% | ||
| Current year | -18.18% |
1 week
3.34
4.22
1 month
3.284.22
Current year
3.285.06
1 year
3.286.42
3 years
3.2848.40
5 years
3.2869.80
10 years
3.2869.80
| Managers | Title | Age | Since |
|---|---|---|---|
Zhi He
FOU | Founder | 40 | 14-12-08 |
Ji Ming Xu
FOU | Founder | 40 | 14-12-08 |
Ying Ying Gong
FOU | Founder | 39 | 14-12-08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming Zeng
BRD | Director/Board Member | 54 | 21-06-24 |
Xiao Ying Feng
DFI | Director of Finance/CFO | 45 | 23-01-31 |
Ying Ying Gong
FOU | Founder | 39 | 14-12-08 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 11 M€ | +6.29% | - | |
| 0.22% | 78 M€ | +7.79% | - | |
| 0.21% | 0 M€ | 0.00% | - | |
| 0.03% | 117 M€ | +7.34% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 4.15 | +7.79% | 5 970 157 |
| 24-04-25 | 3.85 | +2.39% | 2,352,400 |
| 24-04-24 | 3.76 | +3.58% | 3,762,300 |
| 24-04-23 | 3.63 | +3.71% | 2,650,930 |
| 24-04-22 | 3.5 | +3.55% | 3,688,834 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 03:42 am EDT
More quotes
Yidu Tech Inc is a China-based investment holding company that mainly provides medical big data solutions. The Company operates through three segments. The Big Data Platform and Solutions segment is mainly composed of big data platform offerings and other solutions to customers. The Life Science Solutions segment is responsible for providing analysis-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech and medical device companies and other companies. The Health Management Platform and Solutions segment mainly operates research-driven personal health management platforms and provides insurance technology and disease management solutions to insurance companies and agencies. The Company's main data intelligence infrastructure is YiduCore.
Calendar
2024-06-25
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.563
CNY
Average target price
6.427
CNY
Spread / Average Target
+80.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.18% | 522M | |
| +3.41% | 32.18B | |
| +14.14% | 7.33B | |
| +20.71% | 3.83B | |
| -14.26% | 3.23B | |
| -27.90% | 1.25B | |
| -34.43% | 1.12B | |
| +2.01% | 912M | |
| -24.21% | 856M | |
| -38.47% | 859M |
- Stock Market
- Equities
- 2158 Stock
